Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
In one photo in an illustration, recipe medications are seen next to a pill glass in New York, July 23, 2024.
Spencer Platt | Getty Images News | Getty pictures
President Donald Trump’s latest proposal for recipe medicinal prices once again confused the detention of high costs paid by US patients.
Monday the Leader of the White House signed an order low drug costs In the United States, some medications are significantly reduced abroad.
Trump is designed to bring a controversial policy in the first period, which revitalizes and expanding the controversial policy as a “most popular nation” policy, to bring “justice to America” and prices for 59% or more.
Americans pay more for drugs than Europeans. Full stop. This is correct.
Emily area
Head of European Pharmacy Research, Barclays
The United States pays the most of the most in the world for many recipe medicines.
2024 report Rand Corporation found that drug prices in the United States are almost three times higher than 33 high-income countries.
This is due to the lack of a high sophisticated and fragmented compensation system and national price control of the United States.
Drug prices in the United States are usually determined by pharmaceutical companies and are discussed by individual insurers. The governments contradict the other nationalities with many other nations in Europe with direct drug companies with direct drug companies to cover what the state-funded health systems.
Private US insurers are generally known as Eczane beneficial managers (PBMS), tend to be larger and trust the mediators known because they have more price energy. However, they often do it with limited transparency and can be encouraged with more highly valuable drug fees.
Meanwhile, medicines, in turn, claiming that they have helped to finance and develop critical research and development, Trump has long criticized US consumers for an unjust burden.
“Americans pay more for drugs than Europeans. Full stop. It is true. It is true.
“Trump said this (does not like a bad deal.”
The area noted that even if the US consumers usually pay more money for branded drugs, the picture is clear without cutting.
“Although we are very expensive for US pharmaceutical market, we are very expensive and very little price transparency, the surprising parts of the US system are very effective and more than reducing costs,” he said.
According to Rand, 90% of the prescription in the United States compared to 90% of the volume of prescriptions and 90% compared to other advanced nations. These drugs tend to be cheaper for US patients in two-thirds of the cost of the cost by other nations.
Clampdown in pharmaceutical benefit managers
Trump management will give the price goals of drug manufacturers in the next 30 days, and companies will take additional measures even if they do not “significant progress.”
Plans are seen as a loss of weight loss pharmaceutical manufacturers affect popular pharma firms Novo Nordisk and Eli lilli.
Pharma shares have previously been back in this week, and measures can be more severe than expected and faces legal problems. Similar actions by Trump in the firm’s term were eventually blocked by courts.
“MFN (MFN (the most popular nation is most popularizing that the Sector is becoming a formal draft that we think that we think that there is more avenue, we expect the legislation and legislation that we celebrate the UBS analyst in TRI Huynh.
“Price will remain something on our sector, but we see that the Sector of the President Trump is relatively positive.”
Again, the area can be aimed at a measure of the order that aims to limit the role of the private sector PBMs, as a result, a way to reduce US expenses.
“We will cut Middlememen and facilitate the direct sale of medicines at the most popular nation,” President Trump, a truth wrote in a social article.
The efforts of squaging in PBMS have done traction for the fulfilling pressure from the Federal Trade Commission in recent years. Despite the support of Bipartisan, MPs have ever struggled to make any changes in the Congress so far.
The government’s health department will create a mechanism of patients to buy more drugs than direct manufacturers, according to the execution order.
“It’s probably there is an effort to make these pharmaceutical profit managers (PBMS), there is an effort for bad people,” he said.
“I think that you will probably see what the PBMS adds to the system, which is likely to increase the costs to users, to increase the costs to users, to increase the costs.”
